Klebsiella pneumoniae peptide hijacks a Streptococcus pneumoniae permease to subvert pneumococcal growth and colonization.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
08 Apr 2024
Historique:
received: 22 11 2023
accepted: 26 03 2024
medline: 9 4 2024
pubmed: 9 4 2024
entrez: 8 4 2024
Statut: epublish

Résumé

Treatment of pneumococcal infections is limited by antibiotic resistance and exacerbation of disease by bacterial lysis releasing pneumolysin toxin and other inflammatory factors. We identified a previously uncharacterized peptide in the Klebsiella pneumoniae secretome, which enters Streptococcus pneumoniae via its AmiA-AliA/AliB permease. Subsequent downregulation of genes for amino acid biosynthesis and peptide uptake was associated with reduction of pneumococcal growth in defined medium and human cerebrospinal fluid, irregular cell shape, decreased chain length and decreased genetic transformation. The bacteriostatic effect was specific to S. pneumoniae and Streptococcus pseudopneumoniae with no effect on Streptococcus mitis, Haemophilus influenzae, Staphylococcus aureus or K. pneumoniae. Peptide sequence and length were crucial to growth suppression. The peptide reduced pneumococcal adherence to primary human airway epithelial cell cultures and colonization of rat nasopharynx, without toxicity. We identified a peptide with potential as a therapeutic for pneumococcal diseases suppressing growth of multiple clinical isolates, including antibiotic resistant strains, while avoiding bacterial lysis and dysbiosis.

Identifiants

pubmed: 38589539
doi: 10.1038/s42003-024-06113-9
pii: 10.1038/s42003-024-06113-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

425

Subventions

Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
ID : 192067

Informations de copyright

© 2024. The Author(s).

Références

Willyard, C. The drug-resistant bacteria that pose the greatest health threats. Nature 543, 15 (2017).
pubmed: 28252092 doi: 10.1038/nature.2017.21550
Eleraky, N. E., Allam, A., Hassan, S. B. & Omar, M. M. Nanomedicine fight against antibacterial resistance: an overview of the recent pharmaceutical innovations. Pharmaceutics 12, 142 (2020).
pubmed: 32046289 pmcid: 7076477 doi: 10.3390/pharmaceutics12020142
World Health Organization. WHO Publishes List of Bacteria for Which New Antibiotics are Urgently Needed https://www.who.int/en/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (2017).
Asokan, G. V., Ramadhan, T., Ahmed, E. & Sanad, H. WHO Global Priority Pathogens List: a bibliometric analysis of medline-pubmed for knowledge mobilization to infection prevention and control practices in Bahrain. Oman Med. J. 34, 184–193 (2019).
pubmed: 31110624 pmcid: 6505350 doi: 10.5001/omj.2019.37
van der Poll, T. & Opal, S. M. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374, 1543–1556 (2009).
pubmed: 19880020 doi: 10.1016/S0140-6736(09)61114-4
Cillóniz, C., Garcia-Vidal, C., Ceccato, A. & Torres, A. Antimicrobial resistance among Streptococcus pneumoniae in Antimicrobial Resistance in the 21st Century (eds. Fong, I., Shlaes, D., Drlica, K.) 13–38 (Springer, 2018).
Brugger, S. D. et al. Dolosigranulum pigrum cooperation and competition in human nasal microbiota. mSphere 5, e00852–00820 (2020).
pubmed: 32907957 pmcid: 7485692 doi: 10.1128/mSphere.00852-20
Raya Tonetti, F. et al. The respiratory commensal bacterium Dolosigranulum pigrum 040417 improves the innate immune response to Streptococcus pneumoniae. Microorganisms 9, 1324 (2021).
pubmed: 34207076 pmcid: 8234606 doi: 10.3390/microorganisms9061324
Horn, K. J. et al. Corynebacterium species inhibit Streptococcus pneumoniae colonization and infection of the mouse airway. Front. Microbiol. 12, 804935 (2021).
pubmed: 35082772 doi: 10.3389/fmicb.2021.804935
Santagati, M., Scillato, M., Patanè, F., Aiello, C. & Stefani, S. Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol. Med. Microbiol. 65, 23–31 (2012).
pubmed: 22243526 doi: 10.1111/j.1574-695X.2012.00928.x
Horn, K. J., Schopper, M. A., Drigot, Z. G. & Clark, S. E. Airway Prevotella promote TLR2-dependent neutrophil activation and rapid clearance of Streptococcus pneumoniae from the lung. Nat. Commun. 13, 3321 (2022).
pubmed: 35680890 pmcid: 9184549 doi: 10.1038/s41467-022-31074-0
Claverys, J. P., Grossiord, B. & Alloing, G. Is the Ami-AliA/B oligopeptide permease of Streptococcus pneumoniae involved in sensing environmental conditions? Res. Microbiol. 151, 457–463 (2000).
pubmed: 10961459 doi: 10.1016/S0923-2508(00)00169-8
Kerr, A. R. et al. The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease. Infect. Immun. 72, 3902–3906 (2004).
pubmed: 15213133 pmcid: 427416 doi: 10.1128/IAI.72.7.3902-3906.2004
Nasher, F., Heller, M. & Hathaway, L. J. Streptococcus pneumoniae proteins AmiA, AliA, and AliB bind peptides found in ribosomal proteins of other bacterial species. Front. Microbiol. 8, 2688 (2018).
pubmed: 29379482 pmcid: 5775242 doi: 10.3389/fmicb.2017.02688
Nasher, F. et al. Peptide ligands of AmiA, AliA, and AliB proteins determine pneumococcal phenotype. Front. Microbiol. 9, 3013 (2018).
pubmed: 30568648 pmcid: 6290326 doi: 10.3389/fmicb.2018.03013
Lux, J. et al. AmiA and AliA peptide ligands are secreted by Klebsiella pneumoniae and inhibit growth of Streptococcus pneumoniae. Sci. Rep. 12, 22268 (2022).
pubmed: 36564446 pmcid: 9789142 doi: 10.1038/s41598-022-26838-z
Domenech, A., Slager, J. & Veening, J. W. Antibiotic-induced cell chaining triggers pneumococcal competence by reshaping quorum sensing to autocrine-like signaling. Cell Rep. 25, 2390–2400.e2393 (2018).
pubmed: 30485808 pmcid: 6289044 doi: 10.1016/j.celrep.2018.11.007
Slager, J., Aprianto, R. & Veening, J.-W. Refining the pneumococcal competence regulon by RNA sequencing. J. Bacteriol. 201, e00780–00718 (2019).
pubmed: 30885934 pmcid: 6560143 doi: 10.1128/JB.00780-18
Winkler, M. E. & Morrison, D. A. Competence beyond genes: filling in the details of the pneumococcal competence transcriptome by a systems approach. J. Bacteriol. 201, e00238–00219 (2019).
pubmed: 30988030 pmcid: 6560134 doi: 10.1128/JB.00238-19
Kwun, M. J., Ion, A. V., Oggioni, M. R., Bentley, S. D. & Croucher, N. J. Diverse regulatory pathways modulate bet hedging of competence induction in epigenetically-differentiated phase variants of Streptococcus pneumoniae. Nucleic Acids Res. 51, 10375–10394 (2023).
pubmed: 37757859 pmcid: 10602874 doi: 10.1093/nar/gkad760
Gultom, M., Laloli, L. & Dijkman, R. Well-differentiated primary mammalian airway epithelial cell cultures. Methods Mol. Biol. 2203, 119–134 (2020).
pubmed: 32833209 doi: 10.1007/978-1-0716-0900-2_10
Rayamajhi, M., Zhang, Y. & Miao, E. A. Detection of pyroptosis by measuring released lactate dehydrogenase activity. Methods Mol. Biol. 1040, 85–90 (2013).
pubmed: 23852598 pmcid: 3756820 doi: 10.1007/978-1-62703-523-1_7
Basnet, R. M., Zizioli, D., Taweedet, S., Finazzi, D. & Memo, M. Zebrafish larvae as a behavioral model in neuropharmacology. Biomedicines 7, 23 (2019).
pubmed: 30917585 pmcid: 6465999 doi: 10.3390/biomedicines7010023
Rock, S., Rodenburg, F., Schaaf, M. J. M. & Tudorache, C. Detailed analysis of Zebrafish larval behaviour in the light dark challenge assay shows that diel hatching time determines individual variation. Front. Physiol. 13, 827282 (2022).
pubmed: 35480044 pmcid: 9036179 doi: 10.3389/fphys.2022.827282
Rodriguez, J. L., Dalia, A. B. & Weiser, J. N. Increased chain length promotes pneumococcal adherence and colonization. Infect. Immun. 80, 3454–3459 (2012).
pubmed: 22825449 pmcid: 3457561 doi: 10.1128/IAI.00587-12
Hauge, I. H. et al. A novel proteinaceous molecule produced by Lysinibacillus sp. OF-1 depends on the Ami oligopeptide transporter to kill Streptococcus pneumoniae. Microbiology (Reading) 169, 001313 (2023).
pubmed: 36881456 doi: 10.1099/mic.0.001313
Baltzer, S. A. & Brown, M. H. Antimicrobial peptides: promising alternatives to conventional antibiotics. J. Mol. Microbiol. Biotechnol. 20, 228–235 (2011).
pubmed: 21894027
Hirst, R. A., Kadioglu, A., O’Callaghan, C. & Andrew, P. W. The role of pneumolysin in pneumococcal pneumonia and meningitis. Clin. Exp. Immunol. 138, 195–201 (2004).
pubmed: 15498026 pmcid: 1809205 doi: 10.1111/j.1365-2249.2004.02611.x
Tabusi, M. et al. Neuronal death in pneumococcal meningitis is triggered by pneumolysin and RrgA interactions with β-actin. PLoS Pathog. 17, e1009432 (2021).
pubmed: 33760879 pmcid: 7990213 doi: 10.1371/journal.ppat.1009432
Leib, S. L. & Täuber, M. G. Pathogenesis of bacterial meningitis. Infect. Dis. Clin. North Am. 13, 527–548 (1999).
pubmed: 10470554 doi: 10.1016/S0891-5520(05)70093-3
Green, A. E. et al. Airway metabolic profiling during Streptococcus pneumoniae infection identifies branched chain amino acids as signatures of upper airway colonisation. PLoS Pathog. 19, e1011630 (2023).
pubmed: 37669280 pmcid: 10503754 doi: 10.1371/journal.ppat.1011630
Al-Bayati, F. A. et al. Pneumococcal galactose catabolism is controlled by multiple regulators acting on pyruvate formate lyase. Sci. Rep. 7, 43587 (2017).
pubmed: 28240278 pmcid: 5327383 doi: 10.1038/srep43587
Heath, R. J., White, S. W. & Rock, C. O. Lipid biosynthesis as a target for antibacterial agents. Prog. Lipid Res. 40, 467–497 (2001).
pubmed: 11591436 doi: 10.1016/S0163-7827(01)00012-1
Aggarwal, S. D. et al. Competence-associated peptide BriC alters fatty acid biosynthesis in Streptococcus pneumoniae. mSphere 6, e0014521 (2021).
pubmed: 34192504 doi: 10.1128/mSphere.00145-21
Liu, X. et al. High-throughput CRISPRi phenotyping identifies new essential genes in Streptococcus pneumoniae. Mol. Syst. Biol. 13, 931 (2017).
pubmed: 28490437 pmcid: 5448163 doi: 10.15252/msb.20167449
Piotrowski, A., Luo, P. & Morrison, D. A. Competence for genetic transformation in Streptococcus pneumoniae: termination of activity of the alternative sigma factor ComX is independent of proteolysis of ComX and ComW. J. Bacteriol. 191, 3359–3366 (2009).
pubmed: 19286798 pmcid: 2687157 doi: 10.1128/JB.01750-08
Attaiech, L. et al. Role of the single-stranded DNA-binding protein SsbB in pneumococcal transformation: maintenance of a reservoir for genetic plasticity. PLoS Genet. 7, e1002156 (2011).
pubmed: 21738490 pmcid: 3128108 doi: 10.1371/journal.pgen.1002156
Stevens, K. E., Chang, D., Zwack, E. E. & Sebert, M. E. Competence in Streptococcus pneumoniae Is regulated by the rate of ribosomal decoding errors. mBio 2, e00071–00011 (2011).
pubmed: 21933920 pmcid: 3175624 doi: 10.1128/mBio.00071-11
Kausmally, L., Johnsborg, O., Lunde, M., Knutsen, E. & Havarstein, L. S. Choline-binding protein D (CbpD) in Streptococcus pneumoniae is essential for competence-induced cell lysis. J. Bacteriol. 187, 4338–4345 (2005).
pubmed: 15968042 pmcid: 1151764 doi: 10.1128/JB.187.13.4338-4345.2005
Johnsborg, O., Eldholm, V., Bjørnstad, M. L. & Håvarstein, L. S. A predatory mechanism dramatically increases the efficiency of lateral gene transfer in Streptococcus pneumoniae and related commensal species. Mol. Microbiol. 69, 245–253 (2008).
pubmed: 18485065 doi: 10.1111/j.1365-2958.2008.06288.x
Eldholm, V., Johnsborg, O., Haugen, K., Ohnstad, H. S. & Havarstein, L. S. Fratricide in Streptococcus pneumoniae: contributions and role of the cell wall hydrolases CbpD, LytA and LytC. Microbiology (Reading) 155, 2223–2234 (2009).
pubmed: 19389766 doi: 10.1099/mic.0.026328-0
Biornstad, T. J., Ohnstad, H. S. & Havarstein, L. S. Deletion of the murein hydrolase CbpD reduces transformation efficiency in Streptococcus thermophilus. Microbiology (Reading) 158, 877–885 (2012).
pubmed: 22241050 doi: 10.1099/mic.0.056150-0
Cullin, N., Redanz, S., Lampi, K. J., Merritt, J. & Kreth, J. Murein hydrolase LytF of Streptococcus sanguinis and the ecological consequences of competence development. Appl. Environ. Microbiol. 83, e01709–e01717 (2017).
pubmed: 28986373 pmcid: 5717204 doi: 10.1128/AEM.01709-17
Zhu, Y. et al. CrfP, a fratricide protein, contributes to natural transformation in Streptococcus suis. Vet. Res. 52, 50 (2021).
pubmed: 33762005 pmcid: 7992943 doi: 10.1186/s13567-021-00917-x
Hendriksen, W. T. et al. CodY of Streptococcus pneumoniae: link between nutritional gene regulation and colonization. J. Bacteriol. 190, 590–601 (2008).
pubmed: 18024519 doi: 10.1128/JB.00917-07
Weiser, J. N., Ferreira, D. M. & Paton, J. C. Streptococcus pneumoniae: transmission, colonization and invasion. Nat. Rev. Microbiol. 16, 355–367 (2018).
pubmed: 29599457 pmcid: 5949087 doi: 10.1038/s41579-018-0001-8
Cundell, D. R., Pearce, B. J., Sandros, J., Naughton, A. M. & Masure, H. R. Peptide permeases from Streptococcus pneumoniae affect adherence to eucaryotic cells. Infect. Immun. 63, 2493–2498 (1995).
pubmed: 7790061 pmcid: 173333 doi: 10.1128/iai.63.7.2493-2498.1995
Kallio, A. et al. Role of Pht proteins in attachment of Streptococcus pneumoniae to respiratory epithelial cells. Infect. Immun. 82, 1683–1691 (2014).
pubmed: 24491577 pmcid: 3993382 doi: 10.1128/IAI.00699-13
Adamou, J. E. et al. Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect. Immun. 69, 949–958 (2001).
pubmed: 11159990 pmcid: 97974 doi: 10.1128/IAI.69.2.949-958.2001
Uchiyama, S. et al. The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J. Exp. Med. 206, 1845–1852 (2009).
pubmed: 19687228 pmcid: 2737157 doi: 10.1084/jem.20090386
Zhang, J. R., Idanpaan-Heikkila, I., Fischer, W. & Tuomanen, E. I. Pneumococcal licD2 gene is involved in phosphorylcholine metabolism. Mol. Microbiol. 31, 1477–1488 (1999).
pubmed: 10200966 doi: 10.1046/j.1365-2958.1999.01291.x
Engel, H. et al. A low-affinity penicillin-binding protein 2x variant is required for heteroresistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 58, 3934–3941 (2014).
pubmed: 24777105 pmcid: 4068597 doi: 10.1128/AAC.02547-14
Engel, H. et al. Heteroresistance to fosfomycin is predominant in Streptococcus pneumoniae and depends on the murA1 gene. Antimicrob. Agents Chemother. 57, 2801–2808 (2013).
pubmed: 23571543 pmcid: 3716182 doi: 10.1128/AAC.00223-13
Mühlemann, K., Matter, H. C., Täuber, M. G. & Bodmer, T. Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998–1999. J. Infect. Dis. 187, 589–596 (2003).
pubmed: 12599075 doi: 10.1086/367994
Müller, A. et al. Pneumococcal serotype determines growth and capsule size in human cerebrospinal fluid. BMC Microbiol. 20, 16 (2020).
pubmed: 31959125 pmcid: 6971925 doi: 10.1186/s12866-020-1700-7
Ducret, A., Quardokus, E. M. & Brun, Y. V. MicrobeJ, a tool for high throughput bacterial cell detection and quantitative analysis. Nat. Microbiol. 1, 16077 (2016).
pubmed: 27572972 pmcid: 5010025 doi: 10.1038/nmicrobiol.2016.77
Kjos, M. et al. Expression of Streptococcus pneumoniae bacteriocins is induced by antibiotics via regulatory interplay with the competence system. PLoS Pathog. 12, e1005422 (2016).
pubmed: 26840404 pmcid: 4739728 doi: 10.1371/journal.ppat.1005422
Uldry, A.-C. et al. Effect of sample transportation on the proteome of human circulating blood extracellular vesicles. Int. J. Mol. Sci. 23, 4515 (2022).
pubmed: 35562906 pmcid: 9099550 doi: 10.3390/ijms23094515
Faria, M. et al. Acrylamide acute neurotoxicity in adult zebrafish. Sci. Rep. 8, 7918 (2018).
pubmed: 29784925 pmcid: 5962567 doi: 10.1038/s41598-018-26343-2
Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543–D552 (2021).
pmcid: 8728295 doi: 10.1093/nar/gkab1038

Auteurs

Janine Lux (J)

Faculty of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.

Hannah Portmann (H)

Faculty of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Lucía Sánchez García (L)

Faculty of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Maria Erhardt (M)

Faculty of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Lalaina Holivololona (L)

Faculty of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Laura Laloli (L)

Faculty of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Manon F Licheri (MF)

Faculty of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Clement Gallay (C)

Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.

Robert Hoepner (R)

Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland.

Nicholas J Croucher (NJ)

MRC Centre for Global Infectious Disease Analysis, Sir Michael Uren Hub, White City Campus, Imperial College London, London, UK.

Daniel Straume (D)

Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, 1430, Ås, Norway.

Jan-Willem Veening (JW)

Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.

Ronald Dijkman (R)

Faculty of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Manfred Heller (M)

Proteomics and Mass Spectrometry Core Facility, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.

Denis Grandgirard (D)

Faculty of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Stephen L Leib (SL)

Faculty of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Lucy J Hathaway (LJ)

Faculty of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland. lucy.hathaway@unibe.ch.

Classifications MeSH